Levothyroxine Monotherapy and Euthyroidism in Athyreotic Patients
Author Information
Author(s): Gullo Damiano, Latina Adele, Frasca Francesco, Le Moli Rosario, Pellegriti Gabriella, Vigneri Riccardo
Primary Institution: University of Catania Medical School, Garibaldi-Nesima Hospital, Catania, Italy
Hypothesis
Can levothyroxine monotherapy normalize serum thyroid hormones and thyroid-pituitary feedback in athyreotic patients?
Conclusion
Athyreotic patients show a heterogeneous capacity to produce T3 from levothyroxine, with over 20% not maintaining normal FT3 or FT4 levels despite normal TSH.
Supporting Evidence
- 15.2% of levothyroxine-treated patients had lower serum FT3 levels than normal.
- 7.2% had higher serum FT4 levels compared to euthyroid controls.
- 29.6% of patients had FT3/FT4 ratios lower than the normal range.
Takeaway
Some people who take thyroid medicine might not feel better because their bodies can't turn the medicine into the hormone they really need.
Methodology
Retrospective analysis of serum TSH, FT4, and FT3 levels in athyreotic patients under levothyroxine treatment compared to euthyroid controls.
Potential Biases
Potential biases due to the observational nature of the study.
Limitations
The study is retrospective and may have unrecognized confounders.
Participant Demographics
1,811 athyreotic patients (1,530 females, 281 males) and 3,875 euthyroid controls (3,224 females, 651 males).
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website